EOLS
Evolus, Inc. · Healthcare · Market cap $488.8M
Insiders sold $950K net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Sep 4, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.8M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Sep 4, 2026
MOATAZEDI DAVID
Evolus, Inc. (EOLS) has 15 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Sep 4, 2026.
Inside the rolling window, 2 insiders at Evolus, Inc. reported no open-market purchases and 7 open-market sales totaling $1.8M. The most active filer is See Remarks MOATAZEDI DAVID with 4 filings. Insiders have net sold $1.7M over the trailing 6 months. The most recent open-market filing is a sale of 105,108 shares by See Remarks MOATAZEDI DAVID, dated Sep 2, 2026, worth $950K.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:David Moatazedi
- Employees:353
- HQ:Newport Beach, CA, US
- IPO:2018-02-08
| Source | |||||||
|---|---|---|---|---|---|---|---|
| See Remarks | Sale | 105,108 | $950K | Sep 4 | -20.4% | SEC ↗ | |
| See Remarks | Sale | 13,669 | $65K | Mar 20 | +59.5% | SEC ↗ | |
| See Remarks | Sale | 3,119 | $15K | Mar 20 | +59.5% | SEC ↗ | |
| See Remarks | Sale | 29,996 | $147K | Mar 18 | +53.2% | SEC ↗ | |
| See Remarks | Sale | 116,720 | $571K | Mar 18 | +53.2% | SEC ↗ | |
Avelar RuiFirst filing | See Remarks | Sale | 2,261 | $16K | Dec 29 | +11.1% | SEC ↗ |
MOATAZEDI DAVIDFirst filing | See Remarks | Sale | 10,539 | $75K | Dec 29 | +11.1% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does EOLS have?
Evolus, Inc. (EOLS) has 15 SEC Form 4 filings (17 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Sep 4, 2026.
When was the most recent SEC Form 4 filing for EOLS?
The most recent Form 4 filing for EOLS on Tracefour is dated Sep 4, 2026.
Who is the most active insider at EOLS?
The most active SEC Form 4 filer at EOLS in the rolling window is See Remarks MOATAZEDI DAVID, with 4 filings.
What is the net insider flow at EOLS over the last 6 months?
Over the trailing 180 days, insiders at EOLS have net sold $1.7M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at EOLS in the current window?
Inside the rolling window, insiders at EOLS bought $0 and sold $1.8M based on SEC Form 4 filings.
Can I get alerts for EOLS insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Evolus, Inc. (EOLS). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Evolus, Inc. is in the Healthcare sector.